Global Genome Editing/Genome Engineering Market By Type (CRISPR, TALEN, ZFN, Antisense, and Other Technology), By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 136493
- 18-Dec
- PDF/PPT/Word
-
Report Details
The report on Genome Editing/Genome Engineering Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global genome editing/genome engineering market is segmented on the basis of Type, Application, and geography.
The worldwide market for Genome Editing/Genome Engineering Market is expected to grow at a CAGR of roughly x.x% over the next nine years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.
Genome Editing/Genome Engineering Market Scope:
By type, the market is segmented into CRISPR, TALEN, ZFN, Antisense, and Other Technology. By Application, the market is divided into Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other
.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Thermo Fisher Scientific, Merck KGaA, Horizon Discovery, Genscript USA, Sangamo Biosciences, Integrated DNA Technologies, Origene Technologies, Transposagen Biopharmaceuticals, Lonza Group, and New England Biolabs.Key Market Segments
Type
CRISPR
TALEN
ZFN
Antisense
Other Technology
Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other
Key Market Players included in the report:
Thermo Fisher Scientific
Merck KGaA
Horizon Discovery
Genscript USA
Sangamo Biosciences
Integrated DNA Technologies
Origene Technologies
Transposagen Biopharmaceuticals
Lonza Group
New England Biolabs
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Genome Editing/Genome Engineering Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Genome Editing/Genome Engineering Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Genome Editing/Genome Engineering Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Genome Editing/Genome Engineering Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Genome Editing/Genome Engineering Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Genome Editing/Genome Engineering Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Genome Editing/Genome Engineering sub-markets, depending on key regions (various vital states).
To analyze Genome Editing/Genome Engineering Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Genome Editing/Genome Engineering Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
Primary worldwide Genome Editing/Genome Engineering Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Genome Editing/Genome Engineering Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Genome Editing/Genome Engineering Market Overview3.1. Genome Editing/Genome Engineering Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges 3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global Genome Editing/Genome Engineering Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Genome Editing/Genome Engineering Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. CRISPR4.4. TALEN
4.5. ZFN
4.6. Antisense
4.7. Other Technology5. Global Genome Editing/Genome Engineering Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Genome Editing/Genome Engineering Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Cell Line Engineering5.4. Animal Genetic Engineering
5.5. Plant Genetic Engineering
5.6. Other6. Global Genome Editing/Genome Engineering Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Genome Editing/Genome Engineering Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Genome Editing/Genome Engineering Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Genome Editing/Genome Engineering Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America Genome Editing/Genome Engineering Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Genome Editing/Genome Engineering Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Genome Editing/Genome Engineering Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Thermo Fisher Scientific7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments 7.4. Merck KGaA7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments 7.5. Horizon Discovery7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments 7.6. Genscript USA7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments 7.7. Sangamo Biosciences7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments 7.8. Integrated DNA Technologies7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments 7.9. Origene Technologies7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments 7.10. Transposagen Biopharmaceuticals7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments 7.11. Lonza Group7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments 7.12. New England Biolabs7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample